General contact

Main switchboard
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 a.m. - 5:00 p.m. GMT+1

US switchboard

+1 862 778 21 00
Monday - Friday,
8:30 a.m. - 5:00 p.m. EST

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Investors

Investor Relations
Switzerland

Monday - Friday,
8:30 a.m. - 5:30 p.m. GMT+1
(Central European Time)

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

CR guiding principles

Our company's corporate responsibility (CR) efforts are guided by common principles. Responsibility is a core part of our business and underscores our purpose of caring and curing.

  • We apply our expertise in science and innovation to society's biggest health challenges.
  • We take a long-term view and commitment to address global health priorities where we can lead and make a significant impact.
  • We are guided by a central philosophy and programs are conceived of and implemented by our divisions and within our functional areas where the required expertise and infrastructure is strongest.
  • We apply business principles to investments — talent and capital — where the potential for joint value creation is the greatest; philanthropy plays a useful, but limited role.
  • We understand that partnerships are key — improving global health is a goal we share with governments, international agencies, foundations and nongovernmental organizations.
  • We measure and communicate the results of our efforts and the impact on patient and societal health.